骨–血管轴视角下骨质疏松与冠状动脉钙化的关联机制及一体化影像学筛查进展
Research Progress on the Correlation Mechanism between Osteoporosis and Coronary Artery Calcification and Integrated Imaging Screening from the Bone-Vascular Axis Perspective
DOI: 10.12677/acm.2026.1672665, PDF,   
作者: 邵丁旭:温州医科大学研究生院,浙江 温州;冯建钜*:温州医科大学附属诸暨市人民医院放射科,浙江 诸暨
关键词: 骨质疏松冠状动脉钙化骨–血管轴一站式CT机会性筛查人工智能Osteoporosis Coronary Artery Calcification Bone-Vascular Axis One-Stop CT Opportunistic Screening Artificial Intelligence
摘要: 在全球人口老龄化加剧背景下,骨质疏松症与动脉粥样硬化性心血管疾病(ASCVD)已成为中老年人群主要致残、致死性慢性疾病,二者共病进一步加剧不良预后风险。“骨–血管轴”概念的提出揭示二者存在密切的内在关联,骨质疏松与冠状动脉钙化通过“骨–血管轴”形成紧密的病理关联,其共病机制涉及多系统、多通路的协同调控。胸部CT机会性筛查联合人工智能技术为两类疾病的早期识别与风险分层提供了可行的临床路径。但现有证据在因果关系、人群异质性及临床转化路径等方面仍存在争议。本文综合分析近年来国内外相关临床研究与基础实验成果,现有文献多单一探讨机制或影像技术,缺乏对人群异质性、效应修饰因子及临床落地障碍的整合分析。本文从五大维度系统归纳研究现状,剖析现存争议与瓶颈,并讨论该领域面临的挑战与发展趋势,旨在为心骨共病的机制解析、一体化影像筛查标准化及综合防控体系构建提供参考与理论支撑。
Abstract: Against the backdrop of accelerating global population aging, osteoporosis and atherosclerotic cardiovascular disease (ASCVD) have emerged as the leading chronic diseases causing disability and mortality among middle-aged and elderly populations, and their comorbidity further exacerbates the risk of adverse clinical outcomes. The proposal of the “bone-vascular axis” concept reveals an intimate intrinsic linkage between the two disorders. Osteoporosis and coronary artery calcification establish a tight pathological connection via the bone-vascular axis, and their comorbid mechanisms involve synergistic regulation across multiple systems and signaling pathways. Opportunistic chest CT screening combined with artificial intelligence technology provides a feasible clinical strategy for early identification and risk stratification of the two diseases. Nevertheless, controversies remain regarding existing evidence concerning causal relationships, population heterogeneity, and clinical translation pathways. This paper comprehensively analyzes relevant domestic and international clinical studies and basic experimental findings published in recent years. Most available literatures separately discuss pathological mechanisms or imaging techniques, lacking integrated analyses of population heterogeneity, effect modifiers, and barriers to clinical implementation. This review systematically summarizes current research advances from five dimensions, analyzes existing controversies and bottlenecks, and discusses challenges and future trends in this field, aiming to offer references and theoretical support for deciphering the mechanisms underlying bone-cardiac comorbidity, standardizing integrated imaging screening, and constructing a comprehensive prevention and control system.
文章引用:邵丁旭, 冯建钜. 骨–血管轴视角下骨质疏松与冠状动脉钙化的关联机制及一体化影像学筛查进展[J]. 临床医学进展, 2026, 16(7): 1458-1468. https://doi.org/10.12677/acm.2026.1672665

参考文献

[1] 赵勤, 李建飞, 杨进, 张林潮, 漆洁, 韦金儒. 老年人骨密度、骨代谢相关内分泌激素与冠状动脉钙化的相关性研究[J]. 医学临床研究, 2012, 29(9): 1636-1639.
[2] Ye, C., Xu, M., Wang, S., Jiang, S., Chen, X., Zhou, X., et al. (2016) Decreased Bone Mineral Density Is an Independent Predictor for the Development of Atherosclerosis: A Systematic Review and Meta-Analysis. PLOS ONE, 11, e0154740. [Google Scholar] [CrossRef] [PubMed]
[3] Manubolu, V.S., Mao, S., Kinninger, A., Dahal, S., Ahmad, K., Havistin, R., et al. (2023) Association between Coronary Artery Calcium and Thoracic Spine Bone Mineral Density: Multiethnic Study of Atherosclerosis (MESA). Nutrition, Metabolism and Cardiovascular Diseases, 33, 532-540. [Google Scholar] [CrossRef] [PubMed]
[4] Farhat, G.N., Cauley, J.A., Matthews, K.A., Newman, A.B., Johnston, J., Mackey, R., et al. (2006) Volumetric BMD and Vascular Calcification in Middle-Aged Women: The Study of Women's Health across the Nation. Journal of Bone and Mineral Research, 21, 1839-1846. [Google Scholar] [CrossRef] [PubMed]
[5] Hyder, J.A., Allison, M.A., Wong, N., Papa, A., Lang, T.F., Sirlin, C., et al. (2009) Association of Coronary Artery and Aortic Calcium with Lumbar Bone Density: The MESA Abdominal Aortic Calcium Study. American Journal of Epidemiology, 169, 186-194. [Google Scholar] [CrossRef] [PubMed]
[6] Zeng, X., Wang, D., Yang, H., Liu, Z., Li, X., Xiong, T., et al. (2026) Association between Bone Mineral Density and Coronary Artery Calcification: An Updated Systematic Review and Meta-Analysis. BMC Cardiovascular Disorders, 26, Article No. 317. [Google Scholar] [CrossRef
[7] Shen, Y. and Yu, C. (2024) The Bone-Vascular Axis: A Key Player in Chronic Kidney Disease Associated Vascular Calcification. Kidney Diseases, 10, 545-557. [Google Scholar] [CrossRef] [PubMed]
[8] Han, T., Qu, Y., Zhu, J., Sha, L., Lei, B., Xiang, R., et al. (2026) A Comprehensive Multi-Layered Analysis Reveals Genetic Pleiotropy Underlying Coronary Artery Calcification and Bone Mineral Density. Bone, 203, Article ID: 117719. [Google Scholar] [CrossRef
[9] 杨莹, 杨虹, 李玲玲, 等. 骨质疏松与冠状动脉钙化相关机制研究进展[J]. 兰州大学学报(医学版), 2023, 49(4): 76-82.
[10] 赵圆, 邢艳, 刘文亚, 等. 基于定量CT对绝经后无症状冠心病患者腰椎骨密度与冠脉钙化的相关研究[J]. 中国骨质疏松杂志, 2011, 17(12): 1068-1072.
[11] 耿广. 骨和肌肉定量CT指标与冠心病严重程度相关性的研究[D]: [博士学位论文]. 石家庄: 河北医科大学, 2025.
[12] Kim, K.M., Yoon, Y.E., Yun, B.L. and Suh, J. (2022) Association between Bone Mineral Density and Coronary Atherosclerotic Plaque According to Plaque Composition: Registry for the Women Health Cohort for Bone, Breast, and Coronary Artery Disease Study. Journal of Bone Metabolism, 29, 123-131. [Google Scholar] [CrossRef] [PubMed]
[13] Ismaili, J., Poniku, A., Berisha-Muharremi, V., Batalli, A., Tafarshiku, R., Henein, M.Y., et al. (2025) Decreased Bone Mineral Density Is Associated with Subclinical Atherosclerosis in Asymptomatic Non-Diabetic Postmenopausal Women. Journal of Clinical Medicine, 14, Article No. 4033. [Google Scholar] [CrossRef] [PubMed]
[14] Yang, Y., Li, L., Zhang, Y., Yang, H., Bai, J., Lv, H., et al. (2022) Association between Coronary Artery Calcium Score and Bone Mineral Density in Type 2 Diabetes Mellitus with Different Visceral Fat Area. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 15, 3949-3960. [Google Scholar] [CrossRef] [PubMed]
[15] Kim, H., Lee, J., Lee, K., Kim, Y., Hong, N., Park, J.T., et al. (2021) Low Bone Mineral Density Is Associated with Coronary Arterial Calcification Progression and Incident Cardiovascular Events in Patients with Chronic Kidney Disease. Clinical Kidney Journal, 15, 119-127. [Google Scholar] [CrossRef] [PubMed]
[16] Palm, V., Wagner, A., Havlicek, O., Sedaghat, S., Nauck, S., von Stackelberg, O., et al. (2026) Exploring the Bone-Vascular Axis: AI-Augmented Chest CT Analysis in COPD Highlights Association between Vertebral Bone Density and Arterial Calcifications. Respiratory Medicine, 258, Article ID: 108888. [Google Scholar] [CrossRef
[17] 刘梦苑, 郎欣月, 杨进刚, 等. 骨质疏松症与冠状动脉钙化相关性的Meta分析[J]. 中国循环杂志, 2022, 37(8): 810-816.
[18] Lee, D.H., Youn, H., Yi, J.E., Chin, J.Y., Kim, T., Jung, H., et al. (2013) Gender Difference in Bone Loss and Vascular Calcification Associated with Age. Korean Circulation Journal, 43, 453-461. [Google Scholar] [CrossRef] [PubMed]
[19] Luo, J., Wang, Q., Liu, W., Liao, H., Qing, W., Zhang, M., et al. (2025) Computed Tomography Provides a “One-Stop-Shop” Targeted Analysis for Coronary Artery Calcification and Osteoporosis: A Review. Frontiers in Endocrinology (Lausanne), 16, Article ID: 1356831. [Google Scholar] [CrossRef] [PubMed]
[20] 安娜, 张明健, 牛利, 等. 2型糖尿病患者冠状动脉钙化与骨代谢指标的相关性研究[J]. 中国骨质疏松杂志, 2023, 29(8): 1141-1146.
[21] 李娜, 张娟娟, 付智鹏. 老年冠心病患者冠状动脉钙化评分与骨密度及FRAX的关系[J]. 江苏医药, 2021, 47(3): 260-263.
[22] Lu, H., Lary, C.W., Hodonsky, C.J., Peyser, P.A., Bos, D., van der Laan, S.W., et al. (2024) Association between BMD and Coronary Artery Calcification: An Observational and Mendelian Randomization Study. Journal of Bone and Mineral Research, 39, 443-452. [Google Scholar] [CrossRef] [PubMed]
[23] Malluche, H.H., Blomquist, G., Monier-Faugere, M., Cantor, T.L. and Davenport, D.L. (2015) High Parathyroid Hormone Level and Osteoporosis Predict Progression of Coronary Artery Calcification in Patients on Dialysis. Journal of the American Society of Nephrology, 26, 2534-2544. [Google Scholar] [CrossRef] [PubMed]
[24] Waitupu, A., Pratiwi, L., Sutanto, H., et al. (2025) Molecular Pathophysiology of Chronic Kidney Disease-Mineral and Bone Disorder: Focus on the Fibroblast Growth Factor 23-Klotho Axis and Bone Turnover Dynamics. Experimental Physiology, 1-13.
[25] Pendón-Ruiz de Mier, M.V., Santamaría, R., Moyano-Peregrín, C., Gordillo, J.E., Salmoral-Chamizo, A., López-López, I., et al. (2024) Bone and Vascular Effects of Magnesium Supplements in CKD Patients (the Magicalbone Pilot Study). Nefrología (English Edition), 44, 721-730. [Google Scholar] [CrossRef] [PubMed]
[26] Cannata-Andía, J.B., Carrillo-López, N., Messina, O.D., Hamdy, N.A.T., Panizo, S. and Ferrari, S.L. (2021) Pathophysiology of Vascular Calcification and Bone Loss: Linked Disorders of Ageing? Nutrients, 13, Article No. 3835. [Google Scholar] [CrossRef] [PubMed]
[27] Bucay, N., Sarosi, I., Dunstan, C.R., Morony, S., Tarpley, J., Capparelli, C., et al. (1998) Osteoprotegerin-Deficient Mice Develop Early Onset Osteoporosis and Arterial Calcification. Genes & Development, 12, 1260-1268. [Google Scholar] [CrossRef] [PubMed]
[28] Zhang, L., Zeng, F., Jiang, M., Han, M. and Huang, B. (2022) Roles of Osteoprotegerin in Endocrine and Metabolic Disorders through Receptor Activator of Nuclear Factor Kappa-B Ligand/Receptor Activator of Nuclear Factor Kappa-B Signaling. Frontiers in Cell and Developmental Biology, 10, Article ID: 1005681. [Google Scholar] [CrossRef] [PubMed]
[29] Samelson, E.J., Miller, P.D., Christiansen, C., Daizadeh, N.S., Grazette, L., Anthony, M.S., et al. (2014) RANKL Inhibition with Denosumab Does Not Influence 3-Year Progression of Aortic Calcification or Incidence of Adverse Cardiovascular Events in Postmenopausal Women with Osteoporosis and High Cardiovascular Risk. Journal of Bone and Mineral Research, 29, 450-457. [Google Scholar] [CrossRef] [PubMed]
[30] Register, T.C., Hruska, K.A., Divers, J., Bowden, D.W., Palmer, N.D., Carr, J.J., et al. (2014) Sclerostin Is Positively Associated with Bone Mineral Density in Men and Women and Negatively Associated with Carotid Calcified Atherosclerotic Plaque in Men from the African American-Diabetes Heart Study. The Journal of Clinical Endocrinology & Metabolism, 99, 315-321. [Google Scholar] [CrossRef] [PubMed]
[31] Lin, Y., Jiang, P., Lv, Y. and Tian, W. (2026) Postmenopausal Osteoporosis and Vascular Calcification: The Estrogen Regulation Network and Calcification Paradox. Journal of Translational Internal Medicine, 14, 192-203. [Google Scholar] [CrossRef
[32] Weng, S., Ding, C., Shi, Y., Zhang, H., Zhao, W., Zhu, J., et al. (2026) Osteoporosis Therapies and Coronary Risk: Insights from Vascular Calcification Biology and Sclerostin Signaling. Frontiers in Endocrinology, 17, Article ID: 1839111. [Google Scholar] [CrossRef
[33] Zhang, N., Wang, L., Li, X., Yang, X., Tao, X., Jiang, H., et al. (2025) Role of Sclerostin in Cardiovascular System. International Journal of Molecular Sciences, 26, Article No. 4552. [Google Scholar] [CrossRef] [PubMed]
[34] Ferrières, L., Laroche, M., Degboé, Y., Jaafar, A. and Ferrières, J. (2025) The Serum Levels of FGF23, Sclerostin, Osteoprotegerin Do Not Explain the Inverse Relationship between Coronary Calcifications and Bone Mineral Density Evaluated Using Computed Tomography. Frontiers in Cardiovascular Medicine, 12, Article ID: 1583124. [Google Scholar] [CrossRef] [PubMed]
[35] 卢维晟, 张江蓉, 高艳虹, 等. 血清骨钙素水平与老年骨质疏松及冠状动脉病变的相关性[J]. 中国医药, 2013, 8(11): 1612-1614.
[36] Wei, X., Huang, X., Liu, N., Qi, B., Fang, S. and Zhang, Y. (2021) Understanding the Stony Bridge between Osteoporosis and Vascular Calcification: Impact of the FGF23/Klotho Axis. Oxidative Medicine and Cellular Longevity, 2021, Article ID: 7536614. [Google Scholar] [CrossRef] [PubMed]
[37] Mattinzoli, D., Rastaldi, M.P., Ikehata, M., Armelloni, S., Pignatari, C., Giardino, L.A., et al. (2016) FGF23-Regulated Production of Fetuin-A (AHSG) in Osteocytes. Bone, 83, 35-47. [Google Scholar] [CrossRef] [PubMed]
[38] Wungu, C.D.K., Susilo, H., Alsagaff, M.Y., Witarto, B.S., Witarto, A.P., Pakpahan, C., et al. (2024) Role of Klotho and Fibroblast Growth Factor 23 in Arterial Calcification, Thickness, and Stiffness: A Meta-Analysis of Observational Studies. Scientific Reports, 14, Article No. 5712. [Google Scholar] [CrossRef] [PubMed]
[39] Wicik, Z., Jales Neto, L.H., Guzman, L.E.F., Pavão, R., Takayama, L., Caparbo, V.F., et al. (2021) The Crosstalk between Bone Metabolism, lncRNAs, microRNAs and mRNAs in Coronary Artery Calcification. Genomics, 113, 503-513. [Google Scholar] [CrossRef] [PubMed]
[40] He, L., Xu, J., Bai, Y., Zhang, H., Zhou, W., Cheng, M., et al. (2021) MicroRNA-103a Regulates the Calcification of Vascular Smooth Muscle Cells by Targeting Runt-Related Transcription Factor 2 in High Phosphorus Conditions. Experimental and Therapeutic Medicine, 22, Article No. 1036. [Google Scholar] [CrossRef] [PubMed]
[41] Wang, S., Wang, C. and Chen, H. (2020) MicroRNAs Are Critical in Regulating Smooth Muscle Cell Mineralization and Apoptosis during Vascular Calcification. Journal of Cellular and Molecular Medicine, 24, 13564-13572. [Google Scholar] [CrossRef] [PubMed]
[42] Palamar, M., Grosu Radulescu, I.D., Tanasescu, M.D., Sircuta, A. and Bob, F. (2025) Vascular Calcification in Chronic Kidney Disease and Hemodialysis: Pathophysiological Mechanisms and Emerging Biomarkers. Medicina (Kaunas), 61, Article No. 2169. [Google Scholar] [CrossRef
[43] Ghosh, M., Khanam, R., Sengupta, A. and Chakraborty, S. (2024) Oxidative-Stress Induced Bmp2-Smad1/5/8 Signaling Dependent Differentiation of Early Cardiomyocytes from Embryonic and Adult Epicardial Cells. Differentiation, 136, Article ID: 100756. [Google Scholar] [CrossRef] [PubMed]
[44] Mou, K., Chan, S.M.H. and Vlahos, R. (2024) Musculoskeletal Crosstalk in Chronic Obstructive Pulmonary Disease and Comorbidities: Emerging Roles and Therapeutic Potentials. Pharmacology & Therapeutics, 257, Article ID: 108635. [Google Scholar] [CrossRef] [PubMed]
[45] Revel, M.P., Goo, J.M., Vliegenthart, R., et al. (2026) Smoking-Related Comorbidities Detected through Low-Dose CT Imaging Lung Cancer Screening: Current Evidence and Future Directions. Chest, 169, 1457-1458.
[46] Iavrumov, E., Cravcenco, D., Ceasovschih, A., Sivapalan, P., Siafakas, N. and Corlateanu, A. (2026) Assessment of Comorbidities in Chronic Obstructive Pulmonary Disease Patients by Chest High Resolution Computed Tomography (HRCT). Journal of Clinical Medicine, 15, Article No. 785. [Google Scholar] [CrossRef
[47] Cortiana, V., Vaghela, H., Bakhle, R., Santhosh, T., Kaiwan, O., Tausif, A., et al. (2024) Beyond the Heart: The Predictive Role of Coronary Artery Calcium Scoring in Non-Cardiovascular Disease Risk Stratification. Diagnostics (Basel), 14, Article No. 2349. [Google Scholar] [CrossRef] [PubMed]
[48] 王倩. 2型糖尿病椎体骨密度与冠状动脉钙化的DECT定量研究[D]: [硕士学位论文]. 衡阳: 南华大学, 2024.
[49] Guzman, L.F.E., Lopes, N.H.M., Torres, G.H.F., Takayama, L., de Sousa Andrade, S., Lanz-Luces, J.R., et al. (2022) Coronary Calcification and Bone Microarchitecture by High-Resolution Peripheral Quantitative Computed Tomography from the São Paulo Ageing and Health (SPAH) Study. Scientific Reports, 12, Article No. 5282. [Google Scholar] [CrossRef] [PubMed]
[50] Naghavi, M., De Oliveira, I., Mao, S.S., Jaberzadeh, A., Montoya, J., Zhang, C., et al. (2023) Opportunistic AI-Enabled Automated Bone Mineral Density Measurements in Lung Cancer Screening and Coronary Calcium Scoring CT Scans Are Equivalent. European Journal of Radiology Open, 10, Article ID: 100492. [Google Scholar] [CrossRef] [PubMed]
[51] Geers, J., Bing, R., Pawade, T.A., Doris, M.K., Daghem, M., Fletcher, A.J., et al. (2024) Effect of Denosumab or Alendronate on Vascular Calcification: Secondary Analysis of SALTIRE2 Randomized Controlled Trial. Journal of the American Heart Association, 13, e032571. [Google Scholar] [CrossRef] [PubMed]